Intraocular Melanoma Completed Phase 1 Trials for Agatolimod (DB15018)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00471471Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryTreatment